Skip to main content
OpenTrials

Clinical trial condition

Metabolism and Nutrition Disorder

Explore clinical trials studying Metabolism and Nutrition Disorder. Study availability and eligibility vary by location and protocol.

47 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Metabolism and Nutrition Disorder trial results

Completed

Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity

NCT03548987

Conditions
Body Weight, Metabolism and Nutrition Disorder, Nutrition Disorders, +6 more
Locations
  • Novo Nordisk Investigational Site Anniston, Alabama, United States
  • Novo Nordisk Investigational Site Fresno, California, United States
  • Novo Nordisk Investigational Site San Diego, California, United States
  • Novo Nordisk Investigational Site Alpharetta, Georgia, United States
View all 72 locations
View Trial Details
Completed

STEP 1: Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity

NCT03548935

Conditions
Body Weight, Metabolism and Nutrition Disorder, Nutrition Disorders, +7 more
Locations
  • Novo Nordisk Investigational Site Anniston, Alabama, United States
  • Novo Nordisk Investigational Site Anaheim, California, United States
  • Novo Nordisk Investigational Site Lomita, California, United States
  • Novo Nordisk Investigational Site Spring Valley, California, United States
View all 128 locations
View Trial Details
Completed

Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects With Obesity

NCT02918279

Conditions
Body Weight, Metabolism and Nutrition Disorder, Nutrition Disorders, +6 more
Locations
  • Novo Nordisk Investigational Site Meridian, Idaho, United States
  • Novo Nordisk Investigational Site Baton Rouge, Louisiana, United States
  • Novo Nordisk Investigational Site Baltimore, Maryland, United States
  • Novo Nordisk Investigational Site Minneapolis, Minnesota, United States
View all 33 locations
View Trial Details
Completed

Investigation of Safety and Efficacy of Once-daily Semaglutide in Obese Subjects Without Diabetes Mellitus

NCT02453711

Conditions
Body Weight, Metabolism and Nutrition Disorder, Nutrition Disorders, +6 more
Locations
  • Novo Nordisk Investigational Site Anaheim, California, United States
  • Novo Nordisk Investigational Site San Diego, California, United States
  • Novo Nordisk Investigational Site Golden, Colorado, United States
  • Novo Nordisk Investigational Site Waterbury, Connecticut, United States
View all 74 locations
View Trial Details
Completed

Effect and Safety of Liraglutide 3.0 mg in Subjects With Overweight or Obesity and Type 2 Diabetes Mellitus Treated With Basal Insulin

NCT02963922

Conditions
Body Weight, Metabolism and Nutrition Disorder, Nutrition Disorders, +6 more
Locations
  • Novo Nordisk Investigational Site Birmingham, Alabama, United States
  • Novo Nordisk Investigational Site Concord, California, United States
  • Novo Nordisk Investigational Site Fresno, California, United States
  • Novo Nordisk Investigational Site Jacksonville, Florida, United States
View all 54 locations
View Trial Details
Completed

Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting

NCT02963935

Conditions
Body Weight, Metabolism and Nutrition Disorder, Nutrition Disorders, +6 more
Locations
  • Novo Nordisk Investigational Site Jacksonville, Florida, United States
  • Novo Nordisk Investigational Site Plantation, Florida, United States
  • Novo Nordisk Investigational Site Chicago, Illinois, United States
  • Novo Nordisk Investigational Site Greensboro, North Carolina, United States
View Trial Details

Related conditions